Abstract P6-11-04: The evaluation of ganitumab/metformin plus standard neoadjuvant therapy in high-risk breast cancer: Results from the I-SPY 2 trial
Year: 2017
Type: conference-abstract
Source: Cancer Research
Authors: D Yee, M Paoloni, L van't Veer, A Sanil, C Yau, A Forero, AJ Chien, AM Wallace, S Moulder, KS Albain, HG Kaplan, AD Elias, BB Haley, JC Boughey, KA Kemmer, LA Korde, C Isaacs, S Minton, R Nanda, A DeMichele, JE Lang, MB Buxton, NM Hylton, WF Symmans, J Lyandres, M Hogarth, J Perlmutter, LJ Esserman, DA Berry
Institutions: University of Minnesota, Mayo Clinic, University of California, San Francisco, Loyola University Chicago, University of Washington, University of Alabama at Birmingham, University of California San Diego, University of Chicago, Swedish Medical Center, Berry Consultants, LLC (United States), University of Pennsylvania, University of California, Davis
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2594384289